>_ QFI Terminal
TerminalStocks › ISPC

iSpecimen Inc. (ISPC) Stock

Healthcare · Medical - Diagnostics & Research · US
$1.69 -25.55%
Last updated Sep 20, 2026 14:59 UTC

ISPC Key Statistics

Market Cap$9.39M
P/E (TTM)-0.44
P/S (TTM)4.87
P/B (TTM)2.52
Revenue (TTM)$1.93M
EPS (TTM)$-3.82
Dividend Yield
ROE (TTM)-496.37%
Net Margin-543.68%
Gross Margin1.25%
52W High$8.26
52W Low$0.18
Analyst ViewBuy
Price Target
Employees24
Volume1,546,619

About iSpecimen Inc.

iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.

CEO: Katharyn Field. Company website

ISPC — Frequently Asked Questions

What is the ISPC stock price today?

iSpecimen Inc. (ISPC) trades at $1.69, down 25.55% on the day, as of Sep 20, 2026 14:59 UTC.

What is iSpecimen Inc.'s market cap?

iSpecimen Inc. has a market capitalisation of $9.39M, calculated from the live ISPC share price and shares outstanding.

What is the P/E ratio of ISPC?

ISPC has no meaningful price-to-earnings ratio: iSpecimen Inc. lost $3.82 per share over the last twelve months, and a P/E is only defined on positive earnings.

How much revenue does iSpecimen Inc. make?

iSpecimen Inc. generated revenue of $1.93M over the trailing twelve months, which puts the stock at 4.87 times sales.

What is the 52-week range for ISPC?

ISPC has traded between $0.18 and $8.26 over the past 52 weeks, and the last price is 79.5% below that high.

Is iSpecimen Inc. profitable?

No. iSpecimen Inc. is loss-making, with a net margin of -543.68% over the trailing twelve months.

What is the analyst price target for ISPC?

Wall Street analysts rate ISPC Buy.

What sector is iSpecimen Inc. in?

iSpecimen Inc. is classified under the Healthcare sector and the Medical - Diagnostics & Research industry, and is domiciled in US .

Who is the CEO of iSpecimen Inc.?

Katharyn Field is the chief executive of iSpecimen Inc., which employs 24 people.

Where can I track ISPC in real time?

QFI Terminal shows ISPC with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.

See ISPC live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open ISPC in Terminal See plans

Medical - Diagnostics & Research stocks

TMO Thermo Fisher Scientific Inc. DHR Danaher Corporation IQV IQVIA Holdings Inc. LH Labcorp Holdings Inc. DGX Quest Diagnostics Incorporated ICLR ICON Public Limited Company A Agilent Technologies, Inc. WAT Waters Corporation

More Healthcare stocks

UNH UnitedHealth Group Incorporated CVS CVS Health Corp. MCK McKesson Corporation COR Cencora, Inc. NVO Novo Nordisk A/S CI Cigna Corporation CAH Cardinal Health, Inc. ELV Elevance Health Inc.